Search

Your search keyword '"Taguchi, Senzo"' showing total 21 results
Start Over Author "Taguchi, Senzo"
21 results on '"Taguchi, Senzo"'

2. Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncologic Outcomes: A Propensity Score-Matched Analysis

Author

Yamaguchi, Tomohiro, Akiyoshi, Takashi, Fukunaga, Yosuke, Sakamoto, Takashi, Mukai, Toshiki, Hiyoshi, Yukiharu, Nagasaki, Toshiya, Taguchi, Senzo, Chino, Akiko, Shinozaki, Eiji, Yamaguchi, Kensei, and Konishi, Tsuyoshi

Published
2023
Full Text
View/download PDF

4. Dosimetric comparison between three-dimensional conformal radiotherapy followed by electron beam boost and volumetric modulated arc therapy using concomitant boost for the heart and cardiac segments in patients with left-sided breast cancer at risk for radiation-induced cardiac toxicity

Author

Murakami, Yu, Murakami, Yuki, Kamima, Tatsuya, Oguchi, Masahiko, Abo, Natsumi, Takahashi, Taro, Kaneko, Masahiro, Nakano, Masahiro, Matsubayashi, Fumiyasu, Harada, Arisa, Taguchi, Senzo, Hashimoto, Takeo, and Yoshioka, Yasuo

Published
2022
Full Text
View/download PDF

5. ASO Visual Abstract: Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection in Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncological Outcomes—A Propensity Score-Matched Analysis

Author

Yamaguchi, Tomohiro, Akiyoshi, Takashi, Fukunaga, Yosuke, Sakamoto, Takashi, Mukai, Toshiki, Hiyoshi, Yukiharu, Nagasaki, Toshiya, Taguchi, Senzo, Chino, Akiko, Shinozaki, Eiji, Yamaguchi, Kensei, and Konishi, Tsuyoshi

Published
2023
Full Text
View/download PDF

9. Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer

Author

Konishi, Tsuyoshi, Shinozaki, Eiji, Murofushi, Keiko, Taguchi, Senzo, Fukunaga, Yosuke, Nagayama, Satoshi, Fujimoto, Yoshiya, Akiyoshi, Takashi, Nagasaki, Toshiya, Suenaga, Mitsukuni, Chino, Akiko, Kawachi, Hiroshi, Yamamoto, Noriko, Ishikawa, Yuichi, Oguchi, Masahiko, Ishizuka, Naoki, Ueno, Masashi, and Yamaguchi, Kensei

Published
2019
Full Text
View/download PDF

10. P1106: CLINICAL OUTCOME OF PATIENTS WITH LOCALIZED PRIMARY GASTRIC MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: LONG-TERM FOLLOW-UP RESULTS FROM A SINGLE-INSTITUTION OBSERVATIONAL STUDY.

Author

Hirano, Kei, primary, Yoshida, Kikuaki, additional, Inoue, Norihito, additional, Tsuyama, Naoko, additional, Teramoto, Yukako, additional, Hirano, Mitsuhito, additional, Tanba, Mikako, additional, Yamauchi, Nobuhiko, additional, Shirouchi, Yuko, additional, Ishihara, Yuko, additional, Asai, Hiroaki, additional, Mishima, Yuko, additional, Taguchi, Senzo, additional, Hirasawa, Toshiaki, additional, Takeuchi, Kengo, additional, and Maruyama, Dai, additional

Published
2023
Full Text
View/download PDF

12. Long‐term outcomes and central nervous system relapse in extranodal natural killer/T‐cell lymphoma

Author

Miyazaki, Kana, primary, Suzuki, Ritsuro, additional, Oguchi, Masahiko, additional, Taguchi, Senzo, additional, Amaki, Jun, additional, Maeda, Takeshi, additional, Kubota, Nobuko, additional, Maruyama, Dai, additional, Terui, Yasuhito, additional, Sekiguchi, Nodoka, additional, Takizawa, Jun, additional, Tsukamoto, Hiroyuki, additional, Murayama, Tohru, additional, Ando, Toshihiko, additional, Matsuoka, Hiroshi, additional, Hasegawa, Masatoshi, additional, Wada, Hideho, additional, Sakai, Rika, additional, Kameoka, Yoshihiro, additional, Tsukamoto, Norifumi, additional, Choi, Ilseung, additional, Masaki, Yasufumi, additional, Shimada, Kazuyuki, additional, Fukuhara, Noriko, additional, Utsumi, Takahiko, additional, Uoshima, Nobuhiko, additional, Kagami, Yoshitoyo, additional, Asano, Naoko, additional, Ejima, Yasuo, additional, Katayama, Naoyuki, additional, and Yamaguchi, Motoko, additional

Published
2022
Full Text
View/download PDF

13. Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial)

Author

Akiyoshi, Takashi, primary, Shinozaki, Eiji, additional, Taguchi, Senzo, additional, Chino, Akiko, additional, Hiratsuka, Makiko, additional, Tominaga, Tetsuro, additional, Nonaka, Takashi, additional, Toda, Shigeo, additional, Matoba, Shuichiro, additional, Matsui, Shimpei, additional, Okabayashi, Koji, additional, Mukai, Toshiki, additional, Hiyoshi, Yukiharu, additional, Yamaguchi, Tomohiro, additional, Nagasaki, Toshiya, additional, Yamaguchi, Kensei, additional, Ueno, Masashi, additional, Kuroyanagi, Hiroya, additional, Fukunaga, Yosuke, additional, Ishizuka, Naoki, additional, and Konishi, Tsuyoshi, additional

Published
2022
Full Text
View/download PDF

16. Incidence and Risk Factors of Central Nervous System Relapse in Localized Extranodal NK/T-Cell Lymphoma, Nasal Type: An Analysis of Nkea Study

Author

Miyazaki, Kana, primary, Taguchi, Senzo, additional, Oguchi, Masahiko, additional, Suzuki, Ritsuro, additional, Asano, Naoko, additional, Terui, Yasuhito, additional, Kubota, Nobuko, additional, Saito, Yoshihiro, additional, Maeda, Takeshi, additional, Itasaka, Satoshi, additional, Kobayashi, Yukio, additional, Itami, Jun, additional, Amaki, Jun, additional, Akiba, Takeshi, additional, Murayama, Tohru, additional, Ii, Noriko, additional, Soejima, Toshinori, additional, Yamaguchi, Motoko, additional, and Katayama, Naoyuki, additional

Published
2018
Full Text
View/download PDF

17. Chemoradiation for the treatment of locoregional squamous cell carcinoma of the anal canal: A single center retrospective analysis in Japan.

Author

Takahashi, Ryo, primary, Wakatsuki, Takeru, additional, Shinozaki, Eiji, additional, Taguchi, Senzo, additional, Fujimoto, Yoshiya, additional, Osumi, Hiroki, additional, Ota, Yumiko, additional, MATSUSHIMA, TOMOHIRO, additional, Ogura, Mariko, additional, Ichimura, Takashi, additional, Takahari, Daisuke, additional, Suenaga, Mitsukuni, additional, Chin, Keisho, additional, Oguchi, Masahiko, additional, Ueno, Masashi, additional, and Yamaguchi, Kensei, additional

Published
2018
Full Text
View/download PDF

18. Treatments and outcomes of patients with localized extranodal NK/T-cell lymphoma (ENKL) diagnosed between 2014 and 2021: A cooperative study in Japan.

Author

Miyazaki, Kana, Fujimoto, Ayumi, Taguchi, Senzo, Asano, Naoko, Munakata, Wataru, Hirano, Mitsuhito, Takeuchi, Masahiro, Amaki, Jun, Takizawa, Jun, Fukuhara, Noriko, Sakai, Rika, Maeda, Takeshi, Imagumbai, Toshiyuki, Miyazawa, Yuri, Kameoka, Yoshihiro, Yoshimitsu, Makoto, Tawara, Isao, Ejima, Yasuo, Suzuki, Ritsuro, and Yamaguchi, Motoko

Published
2023
Full Text
View/download PDF

20. Autologous Peripheral Blood Stem Cell Transplantation and Timing of Local Radiation Therapy in Patients With Malignant Lymphoma: Results of the Japanese Radiation Oncology Study Group Questionnaire Survey.

Author

Ishibashi N, Ejima Y, Soejima T, Kawaguchi H, Taguchi S, Ito H, Shimizuguchi T, Isobe K, Hasegawa M, Sasai K, Imai M, Shimoda E, Kaizu H, Okano N, Imagumbai T, and Akimoto T

Subjects
Humans, Female, Middle Aged, Male, Adult, Aged, Surveys and Questionnaires, Japan, Lymphoma radiotherapy, Lymphoma therapy, Radiation Oncology methods, Young Adult, Lymphoma, Non-Hodgkin radiotherapy, Lymphoma, Non-Hodgkin therapy, Adolescent, Hodgkin Disease radiotherapy, Hodgkin Disease therapy, Time Factors, East Asian People, Peripheral Blood Stem Cell Transplantation methods, Transplantation, Autologous
Abstract

Background/aim: Malignant lymphoma (ML) including Hodgkin's lymphoma and non-Hodgkin's lymphoma is often treated with local radiation therapy (RT) in combination with autologous hematopoietic stem cell transplantation (ASCT) to prevent relapse; however, the efficacy and optimal timing of this approach is unclear. In this study, a national survey conducted by the Japanese Radiation Oncology Study Group reviewed ML cases from 2011 to 2019 to determine whether RT should be added to ASCT, focusing on the use of autologous peripheral blood stem cell transplantation (auto-PBSCT), a predominant form of ASCT., Patients and Methods: The survey encompassed 92 patients from 11 institutes, and assessed histological ML types, treatment regimens, timing of RT relative to auto-PBSCT, and associated adverse events., Results: The results indicated no significant differences in adverse events, including myelosuppression, based on the timing of RT in relation to auto-PBSCT. However, anemia was more prevalent when RT was administered before auto-PBSCT, and there was a higher incidence of neutropenia recovery delay in patients receiving RT after auto-PBSCT., Conclusion: This study provides valuable insights into the variable practices of auto-PBSCT and local RT in ML treatment, emphasizing the need for optimized timing of these therapies to improve patient outcomes and reduce complications., (Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)

Published
2024
Full Text
View/download PDF

21. Circulating Cytokine Levels in Patients with Prostate Cancer: Effects of Neoadjuvant Hormonal Therapy and External-beam Radiotherapy.

Author

Tanji N, Kikugawa T, Ochi T, Taguchi S, Sato H, Sato T, Sugahara T, Hamada H, Asai S, and Matsumoto A

Subjects
Aged, Aged, 80 and over, Antineoplastic Agents, Hormonal administration & dosage, Cytokines biosynthesis, Cytokines drug effects, Fibroblast Growth Factor 2 blood, Gene Expression Regulation, Neoplastic drug effects, Gene Expression Regulation, Neoplastic radiation effects, Gonadotropin-Releasing Hormone blood, Humans, Interferon-gamma blood, Male, Middle Aged, Prostatic Neoplasms blood, Prostatic Neoplasms pathology, Radiotherapy, Conformal adverse effects, Vascular Endothelial Growth Factor A blood, Cytokines blood, Neoadjuvant Therapy, Prostatic Neoplasms drug therapy, Prostatic Neoplasms radiotherapy
Abstract

Aim: The aim of the study was to better characterize the temporal induction of inflammatory cytokines in the serum of patients with prostate cancer (PCa) treated with radiotherapy and to ascertain the influence of hormonal therapy upon those expressions., Patients and Methods: Between May 2007 and December 2009, 30 patients with localized PCa were treated with 3-dimensional conformal external-beam radiotherapy. Fifteen patients had received neoadjuvant hormonal therapy using a leuteinizing hormone-releasing hormone (LH-RH) analog for six months prior to radiotherapy. The cytokine levels were collectively measured using a multiplex assay system., Results: Seventeen cytokines were at detectable levels throughout the blood sampling times before and during radiotherapy. Hormonal therapy for six months significantly decreased the serum levels of fibroblast growth factor-2 (FGF2) and vascular endothelial growth factor (VEGF). The levels of epidermal growth factor (EGF), granulocyte-colony stimulating factor (G-CSF), and interferon-gamma (IFNγ) significantly increased during radiotherapy. Most cytokine levels, except for eotaxin, G-CSF, growth-related oncogene (GRO), transforming growth factor-beta (TGFβ)-1 and TGFβ2, significantly increased during radiotherapy compared to the levels observed before radiotherapy., Conclusion: The present study revealed the influence of hormonal, and of radiation therapy on the proinflammatory cytokine levels in the sera of patients with PCa. In addition, neoadjuvant hormonal therapy amplified the radiation-induced alteration of serum cytokines. Further studies to characterize the mechanism underlying a radiation- or hormone-induced inflammatory state are, therefore, necessary., (Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.)

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results